Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Graft-versus-host disease: a review.

Literature DB >> 3305944

Graft-versus-host disease: a review.

A J Barrett.

Abstract

Entities: Disease

Mesh：

Year: 1987 PMID： 3305944 PMCID： PMC1290858 DOI： 10.1177/014107688708000613

Source DB: PubMed Journal: J R Soc Med ISSN： 0141-0768 Impact factor: 5.344

× No keyword cloud information.

31 in total

1. Role of bacterial microflora in development of intestinal lesions from graft-versus-host reaction.

Authors: D W van Bekkum; S Knaan
Journal: J Natl Cancer Inst Date: 1977-03 Impact factor: 13.506

2. Induction of lasting hemopoietic chimerism in a xenogeneic (rat to mouse) model.

Authors: W Müller-Ruchholtz; H K Müller-Hermelink; H U Wottge
Journal: Transplant Proc Date: 1979-03 Impact factor: 1.066

3. Prevention of acute graft-versus-host (GVH) mortality with spleen-absorbed antithymocyte globulin (ATG).

Authors: J J Trentin; K P Judd
Journal: Transplant Proc Date: 1973-03 Impact factor: 1.066

4. Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras.

Authors: J M Jones; R Wilson; P M Bealmear
Journal: Radiat Res Date: 1971-03 Impact factor: 2.841

5. Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts.

Authors: R Storb; R B Epstein; T C Graham; E D Thomas
Journal: Transplantation Date: 1970-03 Impact factor: 4.939

6. Graft-versus-host disease in recipients of syngeneic bone marrow.

Authors: E Gluckman; A Devergie; J Sohier; J H Saurat
Journal: Lancet Date: 1980-02-02 Impact factor: 79.321

Review 7. The major histocompatibility complex--genetics and biology. (First of three parts).

Authors: F H Bach; J J van Rood
Journal: N Engl J Med Date: 1976-10-07 Impact factor: 91.245

8. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression.

Authors: K M Sullivan; H M Shulman; R Storb; P L Weiden; R P Witherspoon; G B McDonald; M M Schubert; K Atkinson; E D Thomas
Journal: Blood Date: 1981-02 Impact factor: 22.113

Graft-versus-host disease: a review.

1. Role of bacterial microflora in development of intestinal lesions from graft-versus-host reaction.

2. Induction of lasting hemopoietic chimerism in a xenogeneic (rat to mouse) model.

3. Prevention of acute graft-versus-host (GVH) mortality with spleen-absorbed antithymocyte globulin (ATG).

4. Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras.

5. Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts.

6. Graft-versus-host disease in recipients of syngeneic bone marrow.

Review 7. The major histocompatibility complex--genetics and biology. (First of three parts).

8. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression.

9. Cyclosporin A for the treatment of graft-versus-host disease in man.

10. Response of graft versus host disease to high doses of methyl prednisolone.

Review 1. Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations.

2. Intestinal graft versus host disease.